Genesis Biologics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
16782 Von Karman Ave Ste 17, Irvine, Cal...Phone Number
(657) 888-6243Website
www.genesisbiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Genesis Biologics
Genesis Biologics Inc is a medical device manufacturer and distributor specializing in orthobiologics, allograft tissue, and soft-tissue repair technologies. They offer a range of products including the Adaptive Autologous Processing System (AAPS) for Platelet Rich Plasma (PRP) and various allograft solutions for sports medicine. Their innovative PRP systems provide customizable platelet concentrations for patient-specific treatments, ensuring safety and clinical efficacy. The company targets healthcare providers in the sports medicine field, focusing on delivering high-quality regenerative products.Explore more
Genesis Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genesis Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Genesis Biologics has recently received funding, and reach out quickly before it becomes old news!
Check out if Genesis Biologics is spiking on competitors!
Genesis Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Genesis Biologics launches new products
Click to see if Genesis Biologics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Genesis Biologics
Funding: Get notified immidiatlly once Genesis Biologics has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Genesis Biologics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Genesis Biologics
Compare insights from companies similar to Genesis Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Genesis Biologics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Genesis Biologics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Genesis Biologics.
Genesis Biologics financials insights
Gather financial insights about Genesis Biologics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$81K
Genesis Biologics Tech Stack
A closer look at the technologies used by Genesis Biologics
See more technologies
Genesis Biologics News & Media
Global Amniotic Membrane Market 2020-2027: Development of Amniotic Membrane-Derived Products Gaining Prominence
DUBLIN, March 16, 2021 /PRNewswire/ -- The "Amniotic Membrane Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Enzyme; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering. Development of Amniotic Membrane-Derived Products to...Global Amniotic Membrane Market Forecast 2020-2027: Growing Applications and Rising Number of Target Patient Population
Dublin, March 15, 2021 (GLOBE NEWSWIRE) -- The "Amniotic Membrane Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Enzyme; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering. Development of Amniotic Membrane-Derived Products to Drive Growth of Amniotic Membrane Market during 2020-2027Global amniotic membrane market is expected to reach US$ 2,577.74 million by 2027 from US$ 1,484.83 million in 2019; it is estimated to grow at a CAGR ofWorldwide Amniotic Membrane Market Industry to 2027 - by Enzyme, Application, End-user, and Geography - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Amniotic Membrane Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Enzyme; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering. According to this report the global amniotic membrane market is expected to reach US$ 2,577.74 million by 2027 from US$ 1,484.83 million in 2019; it is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report highlights the trends prevalent in the global
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genesis Biologics
Sign Up For FreeTo access detailed company insights
Genesis Biologics Inc is a medical device manufacturer and distributor specializing in orthobiologics, allograft tissue, and soft-tissue repair technologies. They offer a range of products including the Adaptive Autologous Processing System (AAPS) for Platelet Rich Plasma (PRP) and various allograft solutions for sports medicine. Their innovative P... Read More
